79
38
Andrew R. Haas, M.D., Ph.D.
93
Professor of Medicine (Pulmonary, Allergy and Critical Care) at the Hospital of the University of Pennsylvania
28
78
Bronchoscopy Director, Hospital of the University of Pennsylvania
92
Director, University of Pennsylvania Interventional Pulmonary and Thoracic Oncology Program
78
University Associate Level I, Children's Hospital of Philadelphia
11
3
5f
Department: Medicine
4
1
b
1d
4
3
3
3
2
4
b
1f
13
Education:
21
9
B.S.
14
(Biology)
c
3e
Villanova University, Summa Cum Laude, 1992.
21
a
Ph.D.
2a
(Chemistry & Molecular Biology)
c
53
College of Graduate Studies of Thomas Jefferson University, 1999.
21
9
M.D.
15
(Medicine)
c
5c
Jefferson Medical College of Thomas Jefferson University, Cum Laude, 1999.
c
3
3
21
1f
Post-Graduate Training
24
86
Intern in Medicine, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, 1999-2000.
24
88
Resident in Medicine, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, 2000-2002.
24
92
Fellow, Pulmonary, Allergy, and Critical Care Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, 2002-2005.
24
a9
Interventional Pulmonary Training, Hospital of the University of Pennsylvania, included 5 week intensive training program in rigid bronchoscopy in Marseille, France
2
1b
, 2005-2005.
c
3
25
17
Certifications
28
48
American Board of Internal Medicine - Diplomate, 2002.
28
5b
American Board of Internal Medicine - Pulmonary Disease, Diplomate, 2004.
28
4e
American Board of Internal Medicine – Critical Care Medicine, Diplomate
2
16
, 2005.
28
5b
American Association of Bronchology and Interventional Pulmonology, 2013.
c
3
92
Permanent link
2
29
1d
21
1e
1d
5e
fb
I have an interest in early phase novel immunotherapeutic trials for patients with thoracic malignancies. I work closely with Drs. Steve Albelda and Carl June to translate the pre-clinical animal model data into human clinical trials.
65
35b
My clinical expertise is in interventional pulmonary and thoracic oncology. This relatively nascent field and subspeciality of pulmonary critical care medicine focuses on patients with benign and malignant airway and parenchymal lung disorders and benign and malignant pleural diseases. I perform advanced diagnostic procedures for patients with lung nodules/masses and/or intrathoracic lymphadenopathy. In addition, I peform therapeutic bronchoscopy on patients with benign and malignant airway disorders that might include mechanical or thermal tumor debulking, balloon dilatation, and/or stent placement. Similarly, I perform diagnostic procedures on patients with suspected malignant pleural conditiosn. Lastly, I work closely with several industry partners on the development of new technology for patients with asthma and emphysema.
1a
7
1d
2c
back to top
26
Last updated: 11/25/2025
34
The Trustees of the University of Pennsylvania
c
1f
27
8
